source
- Podcast debates FDA’s handling of Duchenne drugs and upcoming executive changesAllison DeAngelis, Adam Feuerstein and Elaine Chen host this week’s Readout Loud podcast, a STAT series that examines biotech trends and business moves. The trio questions whether the FDA is apply…
- Takeda, Regeneron, Sanofi and Bristol Myers Squibb announce pipeline cuts in quarterly updatesTakeda, Regeneron, Sanofi and Bristol Myers Squibb disclosed that they are trimming several drug development programs as part of their recent earnings releases. The cuts affect a mix of early‑stage…